Drug Approval | September 29, 2023
USFDA delegation visits Divi's Laboratories’ Unit I at Choutuppal, Telangana
The delegation's visit covered a wide range of topics
The delegation's visit covered a wide range of topics
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Commenced operations in flood-affected Himachal Pradesh
India is promoting holistic healthcare with emphasis on preventive care
Subscribe To Our Newsletter & Stay Updated
